More than the Infinite Monkey Theorem: NHP Models in the Development of a Pediatric HIV Cure

Chahroudi, Ann
DOI: https://doi.org/10.1007/s11904-023-00686-6
IF: 5.495
2024-01-17
Current HIV/AIDS Reports
Abstract:An HIV cure that eliminates the viral reservoir or provides viral control without antiretroviral therapy (ART) is an urgent need in children as they face unique challenges, including lifelong ART adherence and the deleterious effects of chronic immune activation. This review highlights the importance of nonhuman primate (NHP) models in developing an HIV cure for children as these models recapitulate the viral pathogenesis and persistence.
infectious diseases
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the unique challenges in developing HIV - curing methods for children. Specifically, the paper focuses on the following aspects: 1. **Formation and Persistence of the Viral Reservoir**: The progression of HIV infection in children is faster than that in adults, resulting in a higher viral load and earlier damage to the immune system. The HIV viral reservoir in children has unique characteristics. For example, it is mainly composed of transitional memory CD4+ T cells, which are less common in adults. Moreover, early initiation of antiretroviral therapy (ART) after neonatal HIV infection can limit the size of the viral reservoir, but it cannot completely eliminate it. 2. **Specialties of the Pediatric Immune System**: The immune system of children has different characteristics during development, such as a bias towards Th2, Th17 and regulatory T cell (Treg) responses, which limits the induction of antiviral cellular immune responses. Therefore, the immune response of children after HIV infection is different from that of adults, and specialized strategies are required to deal with it. 3. **Importance of Non - Human Primate (NHP) Models**: NHP models play a crucial role in studying HIV infection and evaluating potential curing strategies. These models can simulate the pathological process of HIV infection and viral persistence, especially in infants and children. Through NHP models, researchers can evaluate the safety and effectiveness of new treatment methods, while these methods may face ethical and safety issues when tested in humans. 4. **Current and Future Curing Strategies**: The paper discusses some currently explored curing methods, including broadly neutralizing antibodies (bNAbs), adeno - associated virus (AAV) vector - mediated continuous bNAb expression, therapeutic vaccines, and methods combining immunotherapy and latency - reversing agents (LRAs). These strategies need to adapt to the unique characteristics of children's immune systems and viral persistence. In conclusion, this paper aims to better understand the pathological mechanisms of HIV infection in children through the study of NHP models and provide a scientific basis for the development of effective pediatric HIV - curing methods.